Nicotine Potentiation of Excitatory Inputs to Ventral Tegmental Area Dopamine Neurons

Drug-induced changes in synaptic strength are hypothesized to contribute to appetitive behavior and addiction. Nicotine, the major addictive substance in tobacco, activates nicotinic receptors (nAChRs) to initiate a series of adaptive changes at the cellular and circuit levels in brain, particularly...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of neuroscience Vol. 31; no. 18; pp. 6710 - 6720
Main Authors Mao, Danyan, Gallagher, Keith, McGehee, Daniel S.
Format Journal Article
LanguageEnglish
Published United States Society for Neuroscience 04.05.2011
Subjects
Online AccessGet full text
ISSN0270-6474
1529-2401
1529-2401
DOI10.1523/JNEUROSCI.5671-10.2011

Cover

Abstract Drug-induced changes in synaptic strength are hypothesized to contribute to appetitive behavior and addiction. Nicotine, the major addictive substance in tobacco, activates nicotinic receptors (nAChRs) to initiate a series of adaptive changes at the cellular and circuit levels in brain, particularly the ventral tegmental area (VTA). Our laboratory previously reported that nicotine facilitates induction of long-term potentiation (LTP) in VTA dopamine (DA) neurons by increasing glutamate release via activation of α7 nAChRs on the glutamate terminals, suggesting a critical presynaptic contribution of nicotine in LTP induction. In the present study, we used an in vitro exposure paradigm to study the effect of nicotine on excitatory synaptic strength. Brief exposure of nicotine to brain slices from drug-naive adult rats followed by a period of recovery resulted in an NMDA receptor (NMDAR)-dependent increase of AMPA receptor/NMDAR ratio in VTA DA neurons, which is consistent with the induction of LTP. These effects are similar to that induced by a single in vivo nicotine injection intraperitoneally. The induction of synaptic potentiation required excitation of DA neurons mediated by somatodendritic α4β2 nAChRs, as well as enhancement of NMDAR function via D 5 dopamine receptors, also on DA neurons. Nicotine-induced increase of presynaptic glutamate release also contributed to the induction of synaptic plasticity, likely through increased activation of NMDAR. These results identified important receptor systems involved in nicotine-induced long-term changes in excitatory synaptic input to VTA DA neurons. The data also revealed remarkable similarity in the mechanisms underlying synaptic plasticity induced by nicotine and cocaine in the VTA.
AbstractList Drug-induced changes in synaptic strength are hypothesized to contribute to appetitive behavior and addiction. Nicotine, the major addictive substance in tobacco, activates nicotinic receptors (nAChRs) to initiate a series of adaptive changes at the cellular and circuit levels in brain, particularly the ventral tegmental area (VTA). Our laboratory previously reported that nicotine facilitates induction of long-term potentiation (LTP) in VTA dopamine (DA) neurons by increasing glutamate release via activation of α7 nAChRs on the glutamate terminals, suggesting a critical presynaptic contribution of nicotine in LTP induction. In the present study, we used an in vitro exposure paradigm to study the effect of nicotine on excitatory synaptic strength. Brief exposure of nicotine to brain slices from drug-naive adult rats followed by a period of recovery resulted in an NMDA receptor (NMDAR)-dependent increase of AMPA receptor/NMDAR ratio in VTA DA neurons, which is consistent with the induction of LTP. These effects are similar to that induced by a single in vivo nicotine injection intraperitoneally. The induction of synaptic potentiation required excitation of DA neurons mediated by somatodendritic α4β2 nAChRs, as well as enhancement of NMDAR function via D 5 dopamine receptors, also on DA neurons. Nicotine-induced increase of presynaptic glutamate release also contributed to the induction of synaptic plasticity, likely through increased activation of NMDAR. These results identified important receptor systems involved in nicotine-induced long-term changes in excitatory synaptic input to VTA DA neurons. The data also revealed remarkable similarity in the mechanisms underlying synaptic plasticity induced by nicotine and cocaine in the VTA.
Drug-induced changes in synaptic strength are hypothesized to contribute to appetitive behavior and addiction. Nicotine, the major addictive substance in tobacco, activates nicotinic receptors (nAChRs) to initiate a series of adaptive changes at the cellular and circuit levels in brain, particularly the ventral tegmental area (VTA). Our laboratory previously reported that nicotine facilitates induction of long-term potentiation (LTP) in VTA dopamine (DA) neurons by increasing glutamate release via activation of α7 nAChRs on the glutamate terminals, suggesting a critical presynaptic contribution of nicotine in LTP induction. In the present study, we used an in vitro exposure paradigm to study the effect of nicotine on excitatory synaptic strength. Brief exposure of nicotine to brain slices from drug-naive adult rats followed by a period of recovery resulted in an NMDA receptor (NMDAR)-dependent increase of AMPA receptor/NMDAR ratio in VTA DA neurons, which is consistent with the induction of LTP. These effects are similar to that induced by a single in vivo nicotine injection intraperitoneally. The induction of synaptic potentiation required excitation of DA neurons mediated by somatodendritic α4β2 nAChRs, as well as enhancement of NMDAR function via D 5 dopamine receptors, also on DA neurons. Nicotine-induced increase of presynaptic glutamate release also contributed to the induction of synaptic plasticity, likely through increased activation of NMDAR. These results identified important receptor systems involved in nicotine-induced long-term changes in excitatory synaptic input to VTA DA neurons. The data also revealed remarkable similarity in the mechanisms underlying synaptic plasticity induced by nicotine and cocaine in the VTA.
Drug-induced changes in synaptic strength are hypothesized to contribute to appetitive behavior and addiction. Nicotine, the major addictive substance in tobacco, activates nicotinic receptors (nAChRs) to initiate a series of adaptive changes at the cellular and circuit levels in brain, particularly the ventral tegmental area (VTA). Our laboratory previously reported that nicotine facilitates induction of long-term potentiation (LTP) in VTA dopamine (DA) neurons by increasing glutamate release via activation of α7 nAChRs on the glutamate terminals, suggesting a critical presynaptic contribution of nicotine in LTP induction. In the present study, we used an in vitro exposure paradigm to study the effect of nicotine on excitatory synaptic strength. Brief exposure of nicotine to brain slices from drug-naive adult rats followed by a period of recovery resulted in an NMDA receptor (NMDAR)-dependent increase of AMPA receptor/NMDAR ratio in VTA DA neurons, which is consistent with the induction of LTP. These effects are similar to that induced by a single in vivo nicotine injection intraperitoneally. The induction of synaptic potentiation required excitation of DA neurons mediated by somatodendritic α4β2 nAChRs, as well as enhancement of NMDAR function via D(5) dopamine receptors, also on DA neurons. Nicotine-induced increase of presynaptic glutamate release also contributed to the induction of synaptic plasticity, likely through increased activation of NMDAR. These results identified important receptor systems involved in nicotine-induced long-term changes in excitatory synaptic input to VTA DA neurons. The data also revealed remarkable similarity in the mechanisms underlying synaptic plasticity induced by nicotine and cocaine in the VTA.Drug-induced changes in synaptic strength are hypothesized to contribute to appetitive behavior and addiction. Nicotine, the major addictive substance in tobacco, activates nicotinic receptors (nAChRs) to initiate a series of adaptive changes at the cellular and circuit levels in brain, particularly the ventral tegmental area (VTA). Our laboratory previously reported that nicotine facilitates induction of long-term potentiation (LTP) in VTA dopamine (DA) neurons by increasing glutamate release via activation of α7 nAChRs on the glutamate terminals, suggesting a critical presynaptic contribution of nicotine in LTP induction. In the present study, we used an in vitro exposure paradigm to study the effect of nicotine on excitatory synaptic strength. Brief exposure of nicotine to brain slices from drug-naive adult rats followed by a period of recovery resulted in an NMDA receptor (NMDAR)-dependent increase of AMPA receptor/NMDAR ratio in VTA DA neurons, which is consistent with the induction of LTP. These effects are similar to that induced by a single in vivo nicotine injection intraperitoneally. The induction of synaptic potentiation required excitation of DA neurons mediated by somatodendritic α4β2 nAChRs, as well as enhancement of NMDAR function via D(5) dopamine receptors, also on DA neurons. Nicotine-induced increase of presynaptic glutamate release also contributed to the induction of synaptic plasticity, likely through increased activation of NMDAR. These results identified important receptor systems involved in nicotine-induced long-term changes in excitatory synaptic input to VTA DA neurons. The data also revealed remarkable similarity in the mechanisms underlying synaptic plasticity induced by nicotine and cocaine in the VTA.
Author McGehee, Daniel S.
Mao, Danyan
Gallagher, Keith
Author_xml – sequence: 1
  givenname: Danyan
  surname: Mao
  fullname: Mao, Danyan
– sequence: 2
  givenname: Keith
  surname: Gallagher
  fullname: Gallagher, Keith
– sequence: 3
  givenname: Daniel S.
  surname: McGehee
  fullname: McGehee, Daniel S.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21543600$$D View this record in MEDLINE/PubMed
BookMark eNqFUcFO3DAQtRAVLNv-Asqtp2xtx4kTqaqEli0sWi1Vy_ZqOc4EXCX2YjsV_H0dFlaUC6d5mvfmzWjeCTo01gBCpwTPSE6zL1frxebn9a_5cpYXnKSxTTEhB2gS2SqlDJNDNMGU47RgnB2jE-__YIw5JvwIHVOSs6zAeII2a61s0AaSHzaACVoGbU1i22TxoHSQwbrHZGm2Q_BJsMnvKHGyS27gto8wojMHMjm3W9mPJmsYnDX-I_rQys7Dp-c6RZvvi5v5Zbq6vljOz1apYiQLKaU5qXgFqiqhylkEeV0rVtQ1qTlw1SgJuICMKVW1DLKsKSPR5KppaFmQNpuibzvf7VD30KjddWLrdC_do7BSi_8Zo-_Erf0rMkJKVpXR4POzgbP3A_ggeu0VdJ00YAcvyiInJS9pFZWnr1ftd7y8MgqKnUA5672Ddi8hWIyZiX1mYsxsbI-ZxcGvbwafHh9jiCfr7r3xf5x-oJU
CitedBy_id crossref_primary_10_1002_cne_24471
crossref_primary_10_1126_science_aaw8806
crossref_primary_10_1016_j_bcp_2013_07_007
crossref_primary_10_3389_fnmol_2017_00338
crossref_primary_10_1016_j_ceca_2017_07_007
crossref_primary_10_3389_fnbeh_2021_649129
crossref_primary_10_1016_j_bbr_2013_11_009
crossref_primary_10_1007_s10059_012_2172_x
crossref_primary_10_1016_j_neuropharm_2020_108256
crossref_primary_10_1016_j_neuropharm_2019_107705
crossref_primary_10_3389_fncel_2014_00466
crossref_primary_10_1371_journal_pone_0087040
crossref_primary_10_1038_npp_2014_265
crossref_primary_10_1016_j_neuropharm_2014_11_014
crossref_primary_10_1523_JNEUROSCI_4647_12_2013
crossref_primary_10_1016_j_pnpbp_2020_109873
crossref_primary_10_1101_cshperspect_a039701
crossref_primary_10_1523_JNEUROSCI_6246_11_2012
crossref_primary_10_3389_fnsys_2017_00050
crossref_primary_10_1016_j_neuropharm_2013_09_008
crossref_primary_10_1016_j_bcp_2017_06_113
crossref_primary_10_3390_molecules24050944
crossref_primary_10_1111_ejn_13425
crossref_primary_10_1038_s41380_023_02194_w
crossref_primary_10_1016_j_phrs_2015_11_016
crossref_primary_10_1016_j_brainres_2012_09_036
crossref_primary_10_1124_mol_113_087346
crossref_primary_10_1111_ejn_12491
crossref_primary_10_1371_journal_pone_0082719
crossref_primary_10_1007_s00213_021_05949_x
crossref_primary_10_1523_ENEURO_0418_19_2020
crossref_primary_10_1101_lm_031237_113
crossref_primary_10_1016_j_neuroscience_2013_08_008
crossref_primary_10_2174_1570159X19666210716112351
crossref_primary_10_1177_1099800418781914
crossref_primary_10_1371_journal_pone_0068300
crossref_primary_10_3390_cells12162051
crossref_primary_10_1111_bph_15762
crossref_primary_10_1016_j_mcna_2021_08_011
crossref_primary_10_1016_j_ypmed_2016_08_009
crossref_primary_10_1016_j_pneurobio_2014_10_002
crossref_primary_10_1016_j_physbeh_2024_114639
crossref_primary_10_3390_brainsci10120928
crossref_primary_10_1126_scisignal_aba1169
crossref_primary_10_1371_journal_pone_0182142
crossref_primary_10_31887_DCNS_2017_19_3_gkoob
crossref_primary_10_3389_fncir_2022_867053
crossref_primary_10_1016_j_tins_2012_02_003
crossref_primary_10_1038_mp_2017_7
crossref_primary_10_1016_j_neuroscience_2015_07_052
crossref_primary_10_1016_j_celrep_2019_04_094
crossref_primary_10_1111_ejn_12114
crossref_primary_10_1172_JCI177833
crossref_primary_10_1080_00952990_2016_1197232
crossref_primary_10_1097_j_pain_0000000000000993
crossref_primary_10_3831_KPI_2020_23_001
crossref_primary_10_1021_acschemneuro_8b00492
crossref_primary_10_1017_jsc_2018_27
Cites_doi 10.1016/S0896-6273(02)00625-6
10.1016/j.neuron.2008.09.009
10.1113/jphysiol.2008.162743
10.1523/JNEUROSCI.22-08-03269.2002
10.1038/npp.2008.143
10.1016/S0022-3565(25)39530-3
10.1002/cne.20417
10.1523/JNEUROSCI.15-07-05379.1995
10.1038/34413
10.1523/JNEUROSCI.3918-08.2008
10.1126/science.1099420
10.1002/1098-2396(200008)37:2<125::AID-SYN7>3.0.CO;2-7
10.1523/JNEUROSCI.21-05-01452.2001
10.1101/lm.70004
10.1073/pnas.0510715103
10.1523/JNEUROSCI.2950-09.2009
10.1038/35079077
10.1523/JNEUROSCI.5095-09.2010
10.1016/j.bcp.2009.05.014
10.1016/j.neuropharm.2004.07.006
10.1523/JNEUROSCI.1001-08.2008
10.1523/JNEUROSCI.5179-05.2006
10.1523/JNEUROSCI.1943-10.2010
10.1038/nrn2234
10.1523/JNEUROSCI.1312-04.2004
10.1523/JNEUROSCI.4331-05.2006
10.1073/pnas.0909184107
10.1016/S0896-6273(00)00042-8
10.1016/j.neuropharm.2010.06.004
10.1016/j.neuropharm.2006.02.003
10.1113/jphysiol.2006.117069
10.1016/S0896-6273(03)00021-7
10.1523/JNEUROSCI.21-15-05841.2001
10.1523/JNEUROSCI.16-07-02411.1996
10.1016/S0028-3908(01)00137-X
10.1073/pnas.88.5.1859
10.1016/j.neuroscience.2006.11.011
10.1113/jphysiol.1992.sp019136
10.1016/0306-4522(94)00536-E
10.1016/S0306-4522(00)00274-8
10.1038/37120
ContentType Journal Article
Copyright Copyright © 2011 the authors 0270-6474/11/316710-11$15.00/0 2011
Copyright_xml – notice: Copyright © 2011 the authors 0270-6474/11/316710-11$15.00/0 2011
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1523/JNEUROSCI.5671-10.2011
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1529-2401
EndPage 6720
ExternalDocumentID PMC3118498
21543600
10_1523_JNEUROSCI_5671_10_2011
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDA NIH HHS
  grantid: DA25875
– fundername: NIDA NIH HHS
  grantid: P01 DA019695
– fundername: NIDA NIH HHS
  grantid: R01 DA025875
– fundername: NIDA NIH HHS
  grantid: R01 DA015918
– fundername: NIDA NIH HHS
  grantid: DA019695
– fundername: NIDA NIH HHS
  grantid: DA015918
GroupedDBID ---
-DZ
-~X
.55
18M
2WC
34G
39C
3O-
53G
5GY
5RE
5VS
AAFWJ
AAJMC
AAYXX
ABBAR
ABIVO
ACGUR
ACNCT
ADBBV
ADCOW
ADHGD
AENEX
AETEA
AFCFT
AFFNX
AFOSN
AFSQR
AHWXS
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
H13
HYE
H~9
KQ8
L7B
MVM
OK1
P0W
P2P
QZG
R.V
RHI
RPM
TFN
TR2
W8F
WH7
WOQ
X7M
XJT
YBU
YHG
YKV
YNH
YSK
AFHIN
AIZTS
CGR
CUY
CVF
ECM
EIF
NPM
RHF
7X8
5PM
ID FETCH-LOGICAL-c413t-2251979ec98e9549ec5bbc46bb1b7e7cdcae06e34cc9f4e33d81b7d5cdd2861f3
ISSN 0270-6474
1529-2401
IngestDate Thu Aug 21 13:18:49 EDT 2025
Fri Sep 05 10:53:13 EDT 2025
Wed Feb 19 02:36:00 EST 2025
Thu Apr 24 23:02:21 EDT 2025
Tue Jul 01 05:27:18 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 18
Language English
License https://creativecommons.org/licenses/by-nc-sa/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c413t-2251979ec98e9549ec5bbc46bb1b7e7cdcae06e34cc9f4e33d81b7d5cdd2861f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jneurosci.org/content/jneuro/31/18/6710.full.pdf
PMID 21543600
PQID 865187829
PQPubID 23479
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3118498
proquest_miscellaneous_865187829
pubmed_primary_21543600
crossref_primary_10_1523_JNEUROSCI_5671_10_2011
crossref_citationtrail_10_1523_JNEUROSCI_5671_10_2011
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-05-04
2011-May-04
20110504
PublicationDateYYYYMMDD 2011-05-04
PublicationDate_xml – month: 05
  year: 2011
  text: 2011-05-04
  day: 04
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of neuroscience
PublicationTitleAlternate J Neurosci
PublicationYear 2011
Publisher Society for Neuroscience
Publisher_xml – name: Society for Neuroscience
References Kalivas (2023041303502037000_31.18.6710.15) 1993; 267
2023041303502037000_31.18.6710.1
2023041303502037000_31.18.6710.27
2023041303502037000_31.18.6710.2
2023041303502037000_31.18.6710.28
2023041303502037000_31.18.6710.29
2023041303502037000_31.18.6710.23
2023041303502037000_31.18.6710.24
Schoffelmeer (2023041303502037000_31.18.6710.34) 2002; 22
Kalivas (2023041303502037000_31.18.6710.16) 1995; 15
2023041303502037000_31.18.6710.25
2023041303502037000_31.18.6710.26
2023041303502037000_31.18.6710.41
2023041303502037000_31.18.6710.20
2023041303502037000_31.18.6710.42
2023041303502037000_31.18.6710.21
2023041303502037000_31.18.6710.22
Ranaldi (2023041303502037000_31.18.6710.30) 2001; 21
Klink (2023041303502037000_31.18.6710.19) 2001; 21
2023041303502037000_31.18.6710.5
2023041303502037000_31.18.6710.6
Vezina (2023041303502037000_31.18.6710.37) 1996; 16
2023041303502037000_31.18.6710.3
2023041303502037000_31.18.6710.4
2023041303502037000_31.18.6710.9
2023041303502037000_31.18.6710.7
2023041303502037000_31.18.6710.8
Johnson (2023041303502037000_31.18.6710.14) 1992; 450
2023041303502037000_31.18.6710.38
2023041303502037000_31.18.6710.17
2023041303502037000_31.18.6710.39
2023041303502037000_31.18.6710.18
2023041303502037000_31.18.6710.12
2023041303502037000_31.18.6710.13
2023041303502037000_31.18.6710.35
2023041303502037000_31.18.6710.36
2023041303502037000_31.18.6710.31
2023041303502037000_31.18.6710.10
2023041303502037000_31.18.6710.32
2023041303502037000_31.18.6710.11
2023041303502037000_31.18.6710.33
2023041303502037000_31.18.6710.40
References_xml – ident: 2023041303502037000_31.18.6710.22
  doi: 10.1016/S0896-6273(02)00625-6
– ident: 2023041303502037000_31.18.6710.10
  doi: 10.1016/j.neuron.2008.09.009
– ident: 2023041303502037000_31.18.6710.40
  doi: 10.1113/jphysiol.2008.162743
– volume: 22
  start-page: 3269
  year: 2002
  ident: 2023041303502037000_31.18.6710.34
  article-title: Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-08-03269.2002
– ident: 2023041303502037000_31.18.6710.9
  doi: 10.1038/npp.2008.143
– volume: 267
  start-page: 486
  year: 1993
  ident: 2023041303502037000_31.18.6710.15
  article-title: Involvement of N-methyl-d-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(25)39530-3
– ident: 2023041303502037000_31.18.6710.24
  doi: 10.1002/cne.20417
– volume: 15
  start-page: 5379
  year: 1995
  ident: 2023041303502037000_31.18.6710.16
  article-title: D1 receptors modulate glutamate transmission in the ventral tegmental area
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.15-07-05379.1995
– ident: 2023041303502037000_31.18.6710.25
  doi: 10.1038/34413
– ident: 2023041303502037000_31.18.6710.29
  doi: 10.1523/JNEUROSCI.3918-08.2008
– ident: 2023041303502037000_31.18.6710.35
  doi: 10.1126/science.1099420
– ident: 2023041303502037000_31.18.6710.6
  doi: 10.1002/1098-2396(200008)37:2<125::AID-SYN7>3.0.CO;2-7
– volume: 21
  start-page: 1452
  year: 2001
  ident: 2023041303502037000_31.18.6710.19
  article-title: Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.21-05-01452.2001
– ident: 2023041303502037000_31.18.6710.27
  doi: 10.1101/lm.70004
– ident: 2023041303502037000_31.18.6710.20
  doi: 10.1073/pnas.0510715103
– ident: 2023041303502037000_31.18.6710.4
  doi: 10.1523/JNEUROSCI.2950-09.2009
– ident: 2023041303502037000_31.18.6710.36
  doi: 10.1038/35079077
– ident: 2023041303502037000_31.18.6710.13
  doi: 10.1523/JNEUROSCI.5095-09.2010
– ident: 2023041303502037000_31.18.6710.28
  doi: 10.1016/j.bcp.2009.05.014
– ident: 2023041303502037000_31.18.6710.39
  doi: 10.1016/j.neuropharm.2004.07.006
– ident: 2023041303502037000_31.18.6710.1
  doi: 10.1523/JNEUROSCI.1001-08.2008
– ident: 2023041303502037000_31.18.6710.33
  doi: 10.1523/JNEUROSCI.5179-05.2006
– ident: 2023041303502037000_31.18.6710.12
  doi: 10.1523/JNEUROSCI.1943-10.2010
– ident: 2023041303502037000_31.18.6710.17
  doi: 10.1038/nrn2234
– ident: 2023041303502037000_31.18.6710.3
  doi: 10.1523/JNEUROSCI.1312-04.2004
– ident: 2023041303502037000_31.18.6710.11
  doi: 10.1523/JNEUROSCI.4331-05.2006
– ident: 2023041303502037000_31.18.6710.31
  doi: 10.1073/pnas.0909184107
– ident: 2023041303502037000_31.18.6710.21
  doi: 10.1016/S0896-6273(00)00042-8
– ident: 2023041303502037000_31.18.6710.42
  doi: 10.1016/j.neuropharm.2010.06.004
– ident: 2023041303502037000_31.18.6710.7
  doi: 10.1016/j.neuropharm.2006.02.003
– ident: 2023041303502037000_31.18.6710.23
  doi: 10.1113/jphysiol.2006.117069
– ident: 2023041303502037000_31.18.6710.32
  doi: 10.1016/S0896-6273(03)00021-7
– volume: 21
  start-page: 5841
  year: 2001
  ident: 2023041303502037000_31.18.6710.30
  article-title: Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.21-15-05841.2001
– volume: 16
  start-page: 2411
  year: 1996
  ident: 2023041303502037000_31.18.6710.37
  article-title: D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.16-07-02411.1996
– ident: 2023041303502037000_31.18.6710.8
  doi: 10.1016/S0028-3908(01)00137-X
– ident: 2023041303502037000_31.18.6710.38
  doi: 10.1073/pnas.88.5.1859
– ident: 2023041303502037000_31.18.6710.2
  doi: 10.1016/j.neuroscience.2006.11.011
– ident: 2023041303502037000_31.18.6710.5
– volume: 450
  start-page: 455
  year: 1992
  ident: 2023041303502037000_31.18.6710.14
  article-title: Two types of neurone in the rat ventral tegmental area and their synaptic inputs
  publication-title: J Physiol
  doi: 10.1113/jphysiol.1992.sp019136
– ident: 2023041303502037000_31.18.6710.41
  doi: 10.1016/0306-4522(94)00536-E
– ident: 2023041303502037000_31.18.6710.18
  doi: 10.1016/S0306-4522(00)00274-8
– ident: 2023041303502037000_31.18.6710.26
  doi: 10.1038/37120
SSID ssj0007017
Score 2.319281
Snippet Drug-induced changes in synaptic strength are hypothesized to contribute to appetitive behavior and addiction. Nicotine, the major addictive substance in...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 6710
SubjectTerms Action Potentials - drug effects
Action Potentials - physiology
Analysis of Variance
Animals
Dopamine - metabolism
Electrophysiology
Immunohistochemistry
Long-Term Potentiation - drug effects
Long-Term Potentiation - physiology
Male
Neurons - drug effects
Neurons - metabolism
Nicotine - pharmacology
Nicotinic Agonists - pharmacology
Rats
Rats, Sprague-Dawley
Receptors, AMPA - metabolism
Receptors, N-Methyl-D-Aspartate - metabolism
Receptors, Nicotinic - metabolism
Synapses - drug effects
Synapses - physiology
Ventral Tegmental Area - drug effects
Ventral Tegmental Area - physiology
Title Nicotine Potentiation of Excitatory Inputs to Ventral Tegmental Area Dopamine Neurons
URI https://www.ncbi.nlm.nih.gov/pubmed/21543600
https://www.proquest.com/docview/865187829
https://pubmed.ncbi.nlm.nih.gov/PMC3118498
Volume 31
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKeOEFAeNSbvID4mVKl8RJnDxW1dhFajW0Fu0tih13G6JJBanE-CP8Xc6xncTdJgF7idq0dpJ-X4-Pj8_5TMgHlPAugoJ7ionEgyFAeqmMCq8MmFKMo2gWxiGns-RoEZ2cx-eDwW8na2nTiJH8dWddyX1QhXOAK1bJ_geyXadwAl4DvnAEhOH4TxgjjA26iad1g1k_nft38FNi7Riunx9X602jZRy-mEDu3lxdWEX_MXiM4EKvixV2onU6bPDua08ix2V1xC-dlNnalqpf90Q7xPD8RbunurpquqDzVB6qS5P8Y6rb985GbuQBQ6mx5zuRRyetdHbz-saChRzmppHZhmekrIUN9ZJO4JpgOxBYqqWOQU24zXpV9q0unbtt-GMtQHEyw_zHs8nxKIaGHua5-8aWO2xYrzQdwNeJWOL7_UDYpSeeTicMJl5Rlj4gD0MOThmu9n_uZei5r7dy7p7Plp7DTezffQtac9pcb9sBujWruZmc63g78yfkscWcjg3nnpKBqp6R3XEFnFpd049UJw7rFZldsmhpSF0a0npJexpSQ0Pa1NTSkHY0pEhD2tKQWho-J4tPB_PJkWd36_AkOEKNF-oa6EzJLFW4dqxkLISMEiECwRWXpSyUnygWSZktI8VYCTMmXsayLMM0CZbsBdmp6kq9IrTMhBKCSQGDQxT7S1SQVTDaYP6WKAM-JHH7E-bSStnjjirfcpzSAgp5h0KOKOBpRGFI9rt2ayPm8tcWtEUoB7uLi2lFperNjzxN4iAF9zobkpcGsK7LFukh4VtQdl9ASfftT6qrSy3tbmn3-t4t35BH_V_1Ldlpvm_UO3CbG_FeU_gPDWvDQA
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nicotine+Potentiation+of+Excitatory+Inputs+to+Ventral+Tegmental+Area+Dopamine+Neurons&rft.jtitle=The+Journal+of+neuroscience&rft.au=Mao%2C+Danyan&rft.au=Gallagher%2C+Keith&rft.au=McGehee%2C+Daniel+S.&rft.date=2011-05-04&rft.pub=Society+for+Neuroscience&rft.issn=0270-6474&rft.eissn=1529-2401&rft.volume=31&rft.issue=18&rft.spage=6710&rft.epage=6720&rft_id=info:doi/10.1523%2FJNEUROSCI.5671-10.2011&rft_id=info%3Apmid%2F21543600&rft.externalDocID=PMC3118498
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-6474&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-6474&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-6474&client=summon